glycyrrhizic acid has been researched along with EBV Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentz, GL; Harrod, AE; Horne, DC; Lowrey, AJ; McKallip, RJ; Nguyen, V; Ross, TD; Satterfield, AR; Uchakina, ON | 1 |
| Cohen, JI | 1 |
| Baltina, L; Baltina, LA; Cherng, JM; Hung, MS; Kondratenko, R; Lin, JC | 1 |
3 other study(ies) available for glycyrrhizic acid and EBV Infections
| Article | Year |
|---|---|
Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency.
Topics: Antiviral Agents; Cell Line; Epstein-Barr Virus Infections; Glycyrrhizic Acid; HEK293 Cells; Herpesvirus 4, Human; Humans; Sumoylation; Virus Latency | 2019 |
Licking latency with licorice.
Topics: Animals; Anti-Infective Agents; Apoptosis; Epstein-Barr Virus Infections; Glycyrrhiza; Glycyrrhizic Acid; Herpesviridae Infections; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Plant Extracts; Virus Activation; Virus Latency | 2005 |
Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships.
Topics: Antigens, Viral; Antiviral Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Gene Dosage; Genome, Viral; Glycyrrhizic Acid; Herpesvirus 4, Human; Humans; Structure-Activity Relationship; Virus Replication | 2008 |